​
​

UpHealth Stock (NYSE:UPH)

RevenueOwnershipFinancialsChartTranscripts
UpHealth by TradingView

Previous Close

$0.27

52W Range

$0.25 - $3.19

50D Avg

$0.84

200D Avg

$1.39

Market Cap

$5.33M

Avg Vol (3M)

$245.88K

Beta

0.51

Div Yield

-

UPH Company Profile

UpHealth, Inc. operates as a digital health services company. It provides a patient-centric digital health technologies and tech-enabled services to manage health and integrate care in the areas of integrated care management, virtual care infrastructure, and services. The company's solutions include Syntranet Core Platform, an integrated care management platform; Cloudbreak, a provider of unified telemedicine solutions and digital health tools; HelloLyf from Glocal, a platform that delivers primary care and specialty consultations; and MedQuest Pharmacy, a full-service retail and compounding licensed pharmacy that dispenses prescribed medications shipped directly to patients. UpHealth, Inc. is headquartered in Delray Beach, Florida.

Show More

Industry

Medical - Healthcare Information Services

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

US

Employees

611

IPO Date

Jul 01, 2019

Website

UPH Performance

Revenue Breakdown

Revenue Breakdown by Product/Service

Product/ServiceDec 22Dec 21
Program Management And Services$4.00M-
Product$35.28M$28.06M
License and Service$12.57M$25.52M
Subscriptions$5.79M$3.04M
Service, Other$110.95M$70.22M
SaaS And Hosting-$49.00K
License--

Fiscal year ends in Dec 22 | Currency in USD

UPH Financial Summary

Dec 22Dec 21Dec 20
Revenue$158.80M$123.80M$5.40M
Operating Income$-25.04M$-44.84M$-1.93M
Net Income$-222.94M$-340.34M$-2.11M
EBITDA$-2.59M$-26.95M$-1.60M
Basic EPS$-15.17$-31.80$-0.40
Diluted EPS$-15.17$-31.80$-0.40

Fiscal year ends in Dec 22 | Currency in USD

Latest Earnings Call Transcripts

Q2 23Aug 10, 23 | 9:45 PM
Q1 23May 12, 23 | 9:21 PM
Q4 22Mar 03, 23 | 10:30 PM

Peer Comparison

TickerCompany
FEMYFemasys Inc.
ENSCEnsysce Biosciences, Inc.
ATIPATI Physical Therapy, Inc.
SHCRSharecare, Inc.